Provided by Tiger Fintech (Singapore) Pte. Ltd.

Outlook Therapeutics, Inc.

1.57
+0.09006.08%
Post-market: 1.570.00000.00%18:42 EDT
Volume:351.28K
Turnover:546.53K
Market Cap:50.27M
PE:-0.39
High:1.57
Open:1.50
Low:1.50
Close:1.48
Loading ...

Outlook Therapeutics 2024 EPS $(4.06) vs $(4.72) YoY

Benzinga
·
27 Dec 2024

Outlook Therapeutics Inc - Commercial Launch of Lytenava in UK and Germany Expected H1 2025

THOMSON REUTERS
·
27 Dec 2024

Outlook Therapeutics® Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update

THOMSON REUTERS
·
27 Dec 2024

Press Release: Outlook Therapeutics(R) Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update

Dow Jones
·
27 Dec 2024

North American Morning Briefing: Stock Futures Fall; Indexes Still on Course to Finish Week Higher

Dow Jones
·
27 Dec 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
19 Dec 2024

Outlook Therapeutics Inc expected to post a loss of 83 cents a share - Earnings Preview

Reuters
·
18 Dec 2024

BRIEF-Outlook Therapeutics Inc - Approves Workforce Reduction To Cut Costs

Reuters
·
17 Dec 2024

Outlook Therapeutics Inc - Approves Workforce Reduction to Cut Costs

THOMSON REUTERS
·
17 Dec 2024

Outlook Therapeutics Inc - Restructuring Payments Expected to Be Complete by Q3 2025

THOMSON REUTERS
·
17 Dec 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
16 Dec 2024

Outlook Therapeutics to Cut 23% Workforce to Lower Costs

MT Newswires Live
·
14 Dec 2024

Outlook Therapeutics to Cut 23% of Workforce in Push for Lytenava Commercial Launch

Dow Jones
·
14 Dec 2024

Outlook Therapeutics to reduce workforce by 23%, streamline operations

TIPRANKS
·
14 Dec 2024

BRIEF-Outlook Therapeutics Streamlines Operations

Reuters
·
14 Dec 2024

Outlook Therapeutics Inc - Announces 23% Workforce Reduction, $1.4 Million Annual Savings

THOMSON REUTERS
·
14 Dec 2024